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OL-019 Effects of HBV on signal transduction of
transforming growth factor-β1 and synthesis of
collagen I in human hepatic stellate cell line,
LX-2 cells
Xiaoning Wu*, Qixuan Bai, Xinmin Li, Tianhui Liu, Jia Li,
Min Cong, Ping Wang, Hong You, Ji-dong Jia. Beijing Friendship
Hospital, Beijing, China
Background and Aims: Transforming growth factor-β1 (TGF-β1)
pathway is key to pathological accumulation of extracellalar
matrix in liver ﬁbrosis, in which collagen type I is the main
component. We aimed to observe the direct effects of HBV on
signal transduction of TGF-β1 and synthesis of collagen type I in
LX-2 cells.
Methods: HBV was puriﬁed by sucrose density gradient centrifu-
gation from human serum. After LX-2 cells cultured with 3.6×105
copies/ml of puriﬁed HBV for 24 and 48 hours, mRNA expression
of collagen type I, TGF-β1, Smad3 and Smad7 were quantiﬁed
by ﬂuorescence-quantiﬁcation real-time PCR;protein expression
were detected with ELISA or Western blot analysis.
Results: When LX-2 cells cultured with puriﬁed HBV for 24 hours;
mRNA expression of TGF-β1, Smad3 and Smad7 were 1.8, 1.7 and
1.2 folds to control respectively; and those were 1.9, 4.3 and
0.3 folds to control for 48 hours. Protein expression of TGF-β1
in supernant did not change signiﬁcantly (P>0.05) for 24 and 48
hours. Protein expression of Smad3 and Smad7 increased after
24 hours, Smad3 kept increasing while Smad7 show no signiﬁcant
differences to control after 48 hours in Western blot analysis.
The mRNA expression of collagen type I were 2.2 and 1.3 folds
to control after 24 and 48 hours; protein expression of collagen
type I in supernant increase signiﬁcantly (P<0.05).
Conclusions: HBV promote expression of TGF-β and its down-
stream moleculars, HBV increase synthesis of collagen type I in
LX-2 cells.
OL-020 Circulating Toll-like receptor (TLR) 2, TLR4, and
CD4+CD25+CD127low/-regulatory T cells correlate
with chronic hepatitis B virus infection
Ye Zhang*, Jian-Qi Lian, Chang-Xing Huang, Jiu-Ping Wang,
Xin Wei, Xue-Ping Nan, Hai-Tao Yu, Xuefan Bai. Center of
Infectious Diseases, Tangdu Hospital, the Fourth Military
Medical University, Xi’an, Shaanxi Province, China
Background: Toll-like receptors (TLRs) play a crucial role in
early host defense by recognizing pathogen-associated molecu-
lar patterns (PAMPs) that are essential for the survival of the
microorganism. CD4+CD25+ regulatory T cells (Tregs) have been
shown to play an important role in maintaining peripheral toler-
ance against self and foreign antigens, and in suppressing T cell
immune response. However, the signiﬁcance of TLRs expression
and Tregs in hepatitis B virus (HBV) infection has not been clearly
described.
Methods: Flow cytometry was performed to assess TLR2 and TLR4
expression on monocytes and circulating CD4+CD25+CD127low/-
Tregs frequency of 16 patients with acute hepatitis B (AHB),
42 patients with chronic hepatitis B (CHB), 22 asymptomatic
carriers (AsC), and 20 healthy controls (NC). Inﬂuence of HBeAg
and HBcAg on TLR2 and TLR4 expression was also investigated.
Results: TLR2 and TLR4 were overexpressed on CD14+ monocytes
in HBV-infected patients as compared with NCs. This result was
conﬁrmed by detection of a clear increase in TLR2 and TLR4
expression in HepG2.2.15 cells compared to HepG2 cells. The
difference in the proportion of Tregs between NCs and CHBs was
signiﬁcant. A negative correlation between TLR4 expression and
Tregs was found in CHBs. TLR2 and TLR4 expression decreased
after HBcAg stimulation in CHBs. Upregulation of TLR2 in NCs and
TLR4 in CHBs was observed following HBeAg incubation.
Conclusions: These results suggest that TLR2, TLR4, and Tregs
correlate closely with HBV infection, and a potentially important
interaction between innate immune responses and immunoregu-
lation during HBV infection.
OL-021 γ-Aminobutyric acid worsen CCL4-induced rat
liver ﬁbrosis
Wenmei Fan*,1, BingYi Shi 1, HongShan Wei2, XiHui Ma1,
Yu Mao3. 1The Center of Organ Transplantation, The Second
Afﬁliated Hospital, The PLA General Hospital; 2Institute of
Infectious Disease, Beijing Ditan Hospital; 3Beijing Ditan
Hospital, Beijing, China
Objective: The mechanism underlying the liver ﬁbrosis is still
not clear. In order to clarify the effect of inhibitory transmitter
in liver ﬁbrosis, we treated rats with liver ﬁbrosis by GABA.
Methods: In the present study, totally 18 rats were randomly
divided into three groups, A group was injected by GABA+CCL4,
B group was injected by CCL4, and C group was normal control.
Liver ﬁbrosis from three groups was evaluated by HE and Mas-
son’s staining. RNA was puriﬁed using the TRizol kit. The gene
expression level was determined by Real-time PCR.
Results: Interestingly, degree of liver ﬁbrosis in group A was de-
teriorated and emerge liver ascites. The mRNA expression level
of α-SMA and TGF-βwere both up-regulated respectively 3.6 and
3.3 times compared with group C, COL I of group A was almost
unchanged compared with group C but only being 10 percent of
group B.
Conclusion: Our results indicated that GABA could fasten the
process of rat liver ﬁbrosis through promoting α-SMA and TGF-
βexpression but not through increasing COL I synthesis.
Acknowledgement: The authors thank Dr. H. Zeng and Professor
J. Chen of Beijing Ditan Hospital for providing us with instru-
ments and technical help. Thank for the support of National
Natural Science Grant (No. 30800509).
OL-022 Antiviral activity of notoginsenoside ST-4 against
herpes simplex virus types 1 and 2
Ying Pei *,1,2, Yang-Fei Xiang1,2, Ying-Jun Zhang3,
Chong-Ren Yang3, Yi-Fei Wang1,2. 1Guangdong Provincial Key
Laboratory of Bioengineering Medicine, Jinan University,
Guangzhou, PR China; 2National Engineering Research Center of
Genetic Medicine, Jinan University, Guangzhou, PR China;
3State Key Laboratory of Phytochemistry and Plant Resources in
West China, Kunming Institute of Botany, Chinese Academy of
Sciences, Kunming, PR China
Background: Herpes simplex viruses (HSV-1 and -2) are impor-
tant pathogens for humans. HSV-1 is associated with orofacial
infections and encephalitis, whereas HSV-2 usually causes genital
infections. The aim of the study was to investigate the antiHSV
activity of notoginsenoside ST-4 and its antiviral action.
Methods: We detected cytotoxic effect using XTT assay and an-
tiviral activity using plaque reduction assay. And we detected the
antiviral action with Virucidal assay, Attachment assay, Penetra-
tion assay and Post-infection Treatment assay. We also detected
the inhibition on HSV DNA synthesis using real-time PCR assay and
HSV protein synthesis tested by immunoﬂuorescence microscopy.
Results: Notoginsenoside ST-4 was isolated from Phyllanthus
emblica, which is a novel compound. It showed low cytotoxic
with the 50% cytotoxic concentration (CC50) of 1.560mg/ml and
strong activity with the 50% inhibitory concentrations (IC50) of
1.889μg/ml against HSV-1 and the IC50 of 2.758μg/ml against
HSV-2. With antiviral action assays, we observed it posses obvi-
ous inhibitory effect on penetration during infections. We also
detected that the inhibition on DNA synthesis and protein syn-
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thesis was not effective. However, the inhibition on penetration
was observed so effective that it can block HSV penetration
completely at the concentration of 0.736μg/ml.
Conclusion: We found that notoginsenoside ST-4 inhibited HSV
infection by blocking the viral penetration. Nowdays in the
absence of HSV vaccines and the emergence of drug-resistant
viruses, notoginsenoside ST-4 represents an important potential
strategy for treatments of HSV infection, especially preventing
the sexual spread of HSV-2.
OL-023 Activation of canonical Wnt signaling pathway
promotes proliferation and self-renewal of rat
hepatic oval cell line WB-F344 in vitro
Ying Zhang*, Fu-kui Zhang, Bao-en Wang. Liver Research Center,
Beijing Friendship Hospital, Beijing, China
Aim: To investigate the effect of activation of canonical Wnt
signaling pathway on the proliferation and differentiation of rat
heaptic oval cells in vitro.
Methods: WB-F344 cells were treated with recombinant wnt3a
(20, 40, 80, 160, 200 ng/ml) in the serum-free medium for 24
hours. Cell proliferation was measured by Brdu incorporation
analysis, un-treated WB-F344 cells were taken as control. After
treatment with Wnt3a (160ng/ml) for 24 hours, the subcellu-
lar localization and protein expression of β-catenin in Wnt3a
treated and untreated WB-F344 cells were examined by Im-
munoﬂuorescence Staining and Western-blot analysis. CyclinD1
mRNA expression was determined by semi-quantitative RT-PCR;
The mRNA levels of some phenotypic markers, including AFP,
CK-19,ALB, and two hepatic nuclear factors, HNF-4, HNF-6 were
determined by RT-PCR. CK-19 and AFP protein expression were
examined by Western-blot analysis.
Results: We found that Wnt3a promoted proliferation of WB-
F344 cells. Stimulation of WB-F344 cells with recombinant Wnt3a
resulted in the accumulation of the transcriptional activator
β-catenin, together with its translocation into the nucleus, and
the upregulation of typical Wnt target genes cyclin D1 After 3
days of Wnt3a treatment in the absence of any serum, these
cells retained their bipotential to express several speciﬁc hepa-
tocyte and cholangiocyte phenotypic markers, such as AFP, CK-19
following activation of canonical Wnt signaling pathway.
Conclusion: The canonical Wnt signaling pathway promotes pro-
liferation and self-renewal of rat hepatic oval cells.
OL-024 vfr: A novel locus affecting cysteine protease
production in Streptococcus pyogenes
Yongsheng Ma*,1,2, Amy Bryant2, Dennis Stevens2. 1Idaho State
University; 2VA Medical Center, USA
Background: Group A streptococcus (GAS) causes many hu-
man diseases ranging in severity from milder infections such
as pharyngitis and cellulitis to life-threatening necrotizing
fasciitis/myonecrosis and streptococcal toxic shock syndrome
(StrepTSS). Multiple extracellular toxins, alone and in com-
bination, are thought to mediate these infections, yet the
mechanisms of toxin regulation are not entirely established.
Methods: In the present study, a single insertion of transposon
Tn917 into the chromosome of a StrepTSS-associated M-type 3
strain of GAS altered the expression of many extracellular pro-
teins, including exotoxins known to be important in pathogenesis.
Results: Expression of the bicistronic gene speB/prsA in the
wild-type strain was not detectable during exponential growth
by northern analysis, but was dramatically activated in the
transposon mutant, suggesting that streptococcal pyrogenic ex-
otoxin B (SpeB) production in the transposon mutant was no
longer growth-phase dependent. Chromosomal localization stud-
ies demonstrated a single transposon insertion into an open
reading frame of a putative 248 amino acid protein, SpyM3_0606.
Complementation of the transposon mutant with a plasmid con-
taining SpyM3_0606 restored the wild-type toxin proﬁle.
Conclusion: This locus is unique to Streptococcus pyogenes and
is distinct from other known global toxin regulators such as CsrRS
and Mga. Due to its effects on extracellular toxins that are
important in pathogenesis, this gene has been designated vfr
for virulence factor related. An understanding of Vfr-mediated
toxin regulation may resolve unanswered questions regarding the
global toxin regulatory network in S. pyogenes.
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OL-025 Hepatitis B virus genotyping: comparison of two
type-speciﬁc primers PCR methods
Hui Jin*,1, Jie Wang1, Zhuo Li 2, Ling Yan1, Jingjing Nie1, Jie Li 1,
Hui Zhuang1. 1Department of Microbiology, Peking University
Health Science Center; 2Beijing You’an Hospital, Capital
University of Medical Sciences, Hepatitis Institute of Beijing
Municipal Health Bureau
Background: To compare and evaluate two type-speciﬁc primers
PCR genotyping methods of hepatitis B virus (HBV) which were
established by Naito et al (Naito method) and our lab (New
method).
Methods: The two genotyping methods were applied for detect-
ing the plasmids containing the HBV genomes of genotype A or D
or subgenotype B1 or C2 and the plasmids mixed with different
proportion of subgenotypes B1 and C2. In addition, the genotypes
of 113 serum samples of patients with chronic HBV infection were
identiﬁed by the two methods, respectively. The results were
veriﬁed by PCR products based sequencing.
Result: The sensitivity of the two methods showed no difference
when they were applied to detect the plasmids containing the
HBV genomes of genotype A or D or subgenotype B1 or C2.
While detecting the plasmids mixed with different proportion
of subgenotypes B1 and C2, the sensitivity of the New method
was superior than that of Naito method. Meanwhile, the speci-
ﬁcity of the New method was obviously superior than that of
Naito method. While detecting the serum samples, the total
discrepancy rate between the two methods was 16.8% (19/113).
Twelve of the 19 inconsistent genotypes by the two methods
were randomly selected and their PCR products were sequenced
directly. The sequencing results were identical with that of the
New methods.
Conclusion: The Newmethod is more sensitive, and its speciﬁcity
is superior to Naito method. It could be used for clinical and epi-
demiological studies on HBV genotype and subgenotype in China.
OL-026 Kinetics of interleukin-18 and HBV DNA during
IFN-therapy induced and spontaneous anti-HBeAg
seroconversion in patients with chronic
hepatitis B
Staffan Sylvan*,1,2, Ulla Hellstrom3,4. 1Dept. of Medical
Sciences, Uppsala University; 2Dept. of Communicable Disease
Control and Prevention, Uppsala County Council; 3Karolinska
Institute; 4Dept. of Communicable Disease Control and
Prevention, Stockholm County Council, Sweden
Background: Interleukin-18 (IL-18) is a Th1-type cytokine that
induce Interferon-gamma (IFN-γ) in T cells, natural killer (NK)
cells, B cells and dendritic cells. In addition IL-18 activates CD8+
T cells, which play a role in viral clearance. Furthermore, it has
been demonstrated that IL-18 inhibits hepatitis B virus replica-
tion in transgenic mice through the induction of IFN-γ. However,
no longitudinal studies to determine whether IL-18 regulation is
associated with viremia and to HBeAg seroconversion in patients
have yet been made.
